Paracetamol to induce ductus arteriosus closure: is it valid?

Allegaert, Karel; Anderson, Brian; Simons, Sinno; van Overmeire, Bart
June 2013
Archives of Disease in Childhood;Jun2013, Vol. 98 Issue 6, p462
Academic Journal
There remains a need for alternative medical treatments for patent ductus arteriosus (PDA) closure in extreme preterm neonates because of therapeutic failure and adverse effects associated with non-selective cyclooxygenase inhibitors. Reports of an association between paracetamol exposure and PDA closure in a limited number of extreme preterm neonates have been published. However, causality cannot be taken for granted because a link between the current knowledge of the clinical pharmacology of paracetamol and (patho) physiology of ductal closure is not known. In contrast to non-selective cyclo-oxygenase inhibitors, paracetamol has limited effects at peripheral sites, is a poor antithrombotic and anti-inflammatory drug and exerts its effects primarily within the central nervous system. Although paracetamol appears an effective and safe analgesic in term and near term neonates, its effectiveness and safety for PDA closure are uncertain because the drug is administered in high doses and there remain a limited number of observations in this specific subpopulation so far. Prospective comparative trials are reasonable and are urgently needed to establish both the effectiveness and safety data of paracetamol when used for this indication.


Related Articles

  • Patent duktus arteriyozuslu erken doÄŸan bir bebekte parasetamol tedavisi. Özdemir, Özmert Muhammet Ali; Küçüktaşçı, Kazım; Doğan, Mustafa; Şahin, Özlem; Ergin, Hacer // Turkish Pediatrics Archive / Turk Pediatri Arsivi;Mar2013, Vol. 48 Issue 1, p82 

    No abstract available.

  • Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial. Dang, Dan; Wang, Dongxuan; Zhang, Chuan; Zhou, Wenli; Zhou, Qi; Wu, Hui // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Trial Design: Oral ibuprofen has demonstrated good effects on symptomatic patent ductus arteriosus (PDA) but with many contraindications and potential side-effects. In the past two years, oral paracetamol administration to several preterm infants with PDA has been reported. Here, a randomized,...

  • Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates. Jasani, B.; Kabra, N.; Nanavati, R. N. // Journal of Postgraduate Medicine;Oct-Dec2013, Vol. 59 Issue 4, p312 

    We herewith report a case series of six premature neonates with hemodynamically significant paten ductus successfully treated with oral paracetamol. This is a first case series describing the use of oral paracetamol treatment patent ductus in preterm neonates from India. Further prospective...

  • Is paracetamol safe and effective for ductus arteriosus closure? Mazer-Amirshahi, Maryann; den Anker, John van // Archives of Disease in Childhood;Oct2013, Vol. 98 Issue 10, p831 

    The article offers information on the study related to use of paracetamol to induce patent ductus arteriosus (PDA) closure. It mentions that PDA is associated with increased morbidity and mortality in preterm infants. It informs that in infants it is treated with cyclooxygenase (COX) inhibitors...

  • Patent ductus arteriosus in premature babies. Chiswick, Malcolm L. // British Medical Journal (Clinical Research Edition);12/5/1981, Vol. 283 Issue 6305, p1490 

    Examines the persisting patency of the ductus arteriosus in premature babies. Resistance of babies receiving respiratory support to weaning from ventilators; Occurence of left-to-right ductal shunts in babies with respiratory distress syndrome; Role of prostaglandins of the E type in...

  • Safety and efficacy of ibuprofen versus indomethacin in preterm infants. Lago, Paola // European Journal of Pediatrics;2003, Vol. 162 Issue 1, p63 

    Comments on the safety and efficacy of cyclo-oxygenase blockers in preterm infants with patent ductus arteriosus (PDA) and respiratory distress syndrome (RDS). Examination of a physiological control group of premature infants; Study of the epidemiology of PDA and RDS.

  • Cyclooxygenase Inhibitors in Preterm Infants With Patent Ductus Arteriosus: Effects on Cardiac and Vascular Indices. Sehgal, Arvind; Doctor, Tejas; Menahem, Samuel // Pediatric Cardiology;Dec2014, Vol. 35 Issue 8, p1429 

    Existing data suggest subendocardial ischemia in preterm infants with patent ductus arteriosus (PDA) and alterations in cardiac function after indomethacin administration. This study aimed to explore the evolution of left ventricular function by conventional echocardiography and speckle-tracking...

  • Paracetamol Therapy for Patent Ductus Arteriosus in Premature Ä°nfants: A Chance Before Surgical Ligation. Özdemir, Özmert; Doğan, Mustafa; Küçüktaşçı, Kazım; Ergin, Hacer; Şahin, Özlem // Pediatric Cardiology;Feb2014, Vol. 35 Issue 2, p276 

    Patent ductus arteriosus (PDA) remains a common problem in premature infants. Treatment options include pharmacologic therapy and surgical ligation, but these are associated with potentially significant adverse effects. This report describes the effect of administering oral paracetamol to...

  • Paracetamol treatment of patent ductus arteriosus in preterm infants. Nadir, E; Kassem, E; Foldi, S; Hochberg, A; Feldman, M // Journal of Perinatology;Oct2014, Vol. 34 Issue 10, p748 

    Objective:To determine the effectiveness of paracetamol in closing patent ductus arteriosus (PDA) in preterm infants of our population.Study Design:Infants with symptomatic PDA who failed or could not get ibuprofen treatment, and who were candidates for surgical ligation, were administered oral...


Read the Article


Sign out of this library

Other Topics